1. Home
  2. TWAV vs CDT Comparison

TWAV vs CDT Comparison

Compare TWAV & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TWAV

TaoWeave Inc. Common Stock

N/A

Current Price

$1.59

Market Cap

5.5M

Sector

Technology

ML Signal

N/A

CDT

Conduit Pharmaceuticals Inc.

N/A

Current Price

$0.69

Market Cap

5.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWAV
CDT
Founded
N/A
2019
Country
United States
United States
Employees
7
4
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TWAV
CDT
Price
$1.59
$0.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8M
2.6M
Earning Date
05-13-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.37
52 Week High
$2.58
$11.00

Technical Indicators

Market Signals
Indicator
TWAV
CDT
Relative Strength Index (RSI) 50.98 33.11
Support Level $1.29 $0.49
Resistance Level $1.86 $0.73
Average True Range (ATR) 0.24 0.22
MACD 0.02 0.05
Stochastic Oscillator 24.22 1.11

Price Performance

Historical Comparison
TWAV
CDT

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Share on Social Networks: